These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 39409041)

  • 1. Solid Lipid Nanoparticles, an Alternative for the Treatment of Triple-Negative Breast Cancer.
    Llaguno-Munive M; Vazquez-Lopez MI; Garcia-Lopez P
    Int J Mol Sci; 2024 Oct; 25(19):. PubMed ID: 39409041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functionalized solid lipid nanoparticles combining docetaxel and erlotinib synergize the anticancer efficacy against triple-negative breast cancer.
    Chaudhuri A; Naveen Kumar D; Kumar D; Kumar Agrawal A
    Eur J Pharm Biopharm; 2024 Aug; 201():114386. PubMed ID: 38950717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DR5 antibody conjugated lipid-based nanocarriers of gamma-secretase inhibitor for the treatment of triple negative breast cancer.
    Pindiprolu SKSS; Krishnamurthy PT; Dev C; Chintamaneni PK
    Chem Phys Lipids; 2021 Mar; 235():105033. PubMed ID: 33385372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid nanocarriers of a lipid-conjugated estrogenic derivative inhibit tumor growth and enhance cisplatin activity against triple-negative breast cancer: pharmacokinetic and efficacy evaluation.
    Andey T; Sudhakar G; Marepally S; Patel A; Banerjee R; Singh M
    Mol Pharm; 2015 Apr; 12(4):1105-20. PubMed ID: 25661724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-CD44 and EGFR Dual-Targeted Solid Lipid Nanoparticles for Delivery of Doxorubicin to Triple-Negative Breast Cancer Cell Line: Preparation, Statistical Optimization, and
    Darabi F; Saidijam M; Nouri F; Mahjub R; Soleimani M
    Biomed Res Int; 2022; 2022():6253978. PubMed ID: 35845934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetically Lethal BMN 673 (Talazoparib) Loaded Solid Lipid Nanoparticles for BRCA1 Mutant Triple Negative Breast Cancer.
    Guney Eskiler G; Cecener G; Egeli U; Tunca B
    Pharm Res; 2018 Sep; 35(11):218. PubMed ID: 30255456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Talazoparib Loaded Solid Lipid Nanoparticles: Preparation, Characterization and Evaluation of the Therapeutic Efficacy In vitro.
    Eskiler GG; Cecener G; Dikmen G; Egeli U; Tunca B
    Curr Drug Deliv; 2019; 16(6):511-529. PubMed ID: 31113350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of pH-Sensitive Cationic PEGylated Solid Lipid Nanoparticles for Selective Cancer-Targeted Therapy.
    Chuang CH; Wu PC; Tsai TH; Fang YP; Tsai YH; Cheng TC; Huang CC; Huang MY; Chen FM; Hsieh YC; Lin WW; Tsai MJ; Cheng TL
    J Biomed Nanotechnol; 2017 Feb; 13(2):192-03. PubMed ID: 29377649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient delivery of curcumin by functional solid lipid nanoparticles with promoting endosomal escape and liver targeting properties.
    Zhang M; Liang J; Liang Y; Li X; Wu W
    Colloids Surf B Biointerfaces; 2024 Dec; 244():114177. PubMed ID: 39217729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation-optimization of solid lipid nanocarrier system of STAT3 inhibitor to improve its activity in triple negative breast cancer cells.
    Pindiprolu SKSS; Chintamaneni PK; Krishnamurthy PT; Ratna Sree Ganapathineedi K
    Drug Dev Ind Pharm; 2019 Feb; 45(2):304-313. PubMed ID: 30348020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth of Metastatic Triple-Negative Breast Cancer Is Inhibited by Deep Tumor-Penetrating and Slow Tumor-Clearing Chemotherapy: The Case of Tumor-Adhering Liposomes with Interstitial Drug Release.
    Stras S; Howe A; Prasad A; Salerno D; Bhatavdekar O; Sofou S
    Mol Pharm; 2020 Jan; 17(1):118-131. PubMed ID: 31825626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery.
    Wu M; Fan Y; Lv S; Xiao B; Ye M; Zhu X
    Drug Deliv; 2016 Oct; 23(8):2720-2725. PubMed ID: 26203691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancing therapeutic efficacy: sustained delivery of 5-fluorouracil (5-FU) via thiolated chitosan nanoparticles targeting CD44 in triple-negative breast cancer.
    Anjum S; Naseer F; Ahmad T; Jahan F; Qadir H; Gul R; Kousar K; Sarwar A; Shabbir A
    Sci Rep; 2024 May; 14(1):11431. PubMed ID: 38763930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving breast cancer therapy using doxorubicin loaded solid lipid nanoparticles: Synthesis of a novel arginine-glycine-aspartic tripeptide conjugated, pH sensitive lipid and evaluation of the nanomedicine in vitro and in vivo.
    Zheng G; Zheng M; Yang B; Fu H; Li Y
    Biomed Pharmacother; 2019 Aug; 116():109006. PubMed ID: 31152925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. pH-Responsive therapeutic solid lipid nanoparticles for reducing P-glycoprotein-mediated drug efflux of multidrug resistant cancer cells.
    Chen HH; Huang WC; Chiang WH; Liu TI; Shen MY; Hsu YH; Lin SC; Chiu HC
    Int J Nanomedicine; 2015; 10():5035-48. PubMed ID: 26346762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of Curcumin-Loaded Solid Lipid Nanoparticles Utilizing Glyceryl Monostearate as Single Lipid Using QbD Approach: Characterization and Evaluation of Anticancer Activity Against Human Breast Cancer Cell Line.
    Bhatt H; Rompicharla SVK; Komanduri N; Aashma S; Paradkar S; Ghosh B; Biswas S
    Curr Drug Deliv; 2018; 15(9):1271-1283. PubMed ID: 29732970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of Glycyrrhetinic Acid and Folate Modified Cantharidin Loaded Solid Lipid Nanoparticles for Targeting Hepatocellular Carcinoma.
    Xu Y; Wang M; Ning S; Yang Z; Zhou L; Xia X
    Molecules; 2022 Oct; 27(20):. PubMed ID: 36296377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Triple-punch" strategy for triple negative breast cancer therapy with minimized drug dosage and improved antitumor efficacy.
    Su S; Tian Y; Li Y; Ding Y; Ji T; Wu M; Wu Y; Nie G
    ACS Nano; 2015 Feb; 9(2):1367-78. PubMed ID: 25611071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solid lipid nanoparticles for thermoresponsive targeting: evidence from spectrophotometry, electrochemical, and cytotoxicity studies.
    Rehman M; Ihsan A; Madni A; Bajwa SZ; Shi D; Webster TJ; Khan WS
    Int J Nanomedicine; 2017; 12():8325-8336. PubMed ID: 29200845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy?
    Qu J; Zhang L; Chen Z; Mao G; Gao Z; Lai X; Zhu X; Zhu J
    Drug Deliv; 2016 Nov; 23(9):3408-3416. PubMed ID: 27181462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.